At this point, many people report improved energy, clearer thinking, and stronger motivation to maintain healthy eating habits
They tend to be most disruptive early in treatment, particularly during dose escalation, and ease up over time for most users
GLP-1 Agonists liraglutide (Saxenda) semaglutide (Wegovy) GIP/GLP-1 Agonist tirzepatide (Zepbound) In addition to helping you lose weight, GLP-1 and dual GIP/GLP-1 agonists can help lower your risk of some conditions that go hand in hand with obesity: type 2 diabetes, heart disease, heart failure, kidney disease, metabolic dysfunctionassociated steatotic liver disease, and obstructive sleep apnea
Nevertheless, it was demonstrated that inadequate weight loss after BS is often associated with increased appetite and an unfavorable postoperative gut hormone profile, including reduced circulating GLP-1 levels [25, 26]